Healthcare and life sciences

Providers, insurers, medical devices, pharmaceuticals and licensing.

We advise clinics, hospitals, clinical laboratories, health insurers, pharmaceutical companies, importers and manufacturers of medical devices, and health technology companies.

We know the structure of the General Social Security Health System under Law 100 of 1993 and Law 1751 of 2015, the supervision of the National Health Superintendence, the procedures before INVIMA (the food and drug agency) and the licensing of health services before the local health authorities, with registration in the REPS (the national registry of health-care providers).

We support day-to-day operations (contracts with insurers, claim denials, medical records, clinical staff) and the major decisions: opening a facility, acquiring a clinic, launching a product or responding to an investigation. Regulatory deadlines in this sector are strict, and we review them with the client from the outset.

How we support

  • We handle the licensing of health services and their registration in the REPS, and prepare providers for verification visits by the health authorities.
  • We obtain marketing authorizations for medicines, medical devices, cosmetics and food products from INVIMA, together with renewals and amendments.
  • We negotiate contracts between providers and insurers: payment models, audits, claim denials and account reconciliation.
  • We advise on collecting receivables from insurers and local governments, including settlement procedures and formal claims.
  • We design the processing of health data and medical records under Law 1581 of 2012, including telemedicine and information systems.
  • We structure the engagement of clinical staff and handle inspections by the Ministry of Labor at clinics and hospitals.
  • We support the purchase, sale and merger of clinics, laboratories and provider networks, with regulatory and health due diligence.
  • We review advertising of medicines, devices and health services, and programs for engaging with health-care professionals.
  • We advise on clinical research: agreements with sponsors and institutions, and approvals from INVIMA and ethics committees.
  • We represent entities and executives in investigations and enforcement proceedings before the National Health Superintendence and INVIMA.

Recurring issues

  • Licensing of new services and facilities
  • Claim denials, receivables and reconciliation with insurers
  • Marketing authorization and post-market surveillance of devices and medicines
  • Medical records, telemedicine and sensitive data
  • Patient claims and institutional liability
  • Engagement of clinical staff: contracts, shifts and outsourcing

Practice areas

Let's talk

Tell us the decision you have to make. We reply the same business day.

Write to us